Research Paper Volume 16, Issue 1 pp 389—401

The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients

class="figure-viewer-img"

Figure 2. The relationship between sarcopenia and OS in TAE or TACE treated HCC patients. (A) The overall analysis; (B) Subgroup analysis including multivariate analysis and univariate analysis.